CDKL5 Pilot Grant Programme
The CDKL5 Pilot Grant Programme from the Loulou Foundation funds innovative research to advance understanding and therapy development for CDKL5 Deficiency Disorder.
Funder: Loulou Foundation
Due Dates (Anticipated): February 2027 (Letter of Intent) | April 2027 (Full application)
Funding Amounts: One-year awards, typically $150,000 total costs per project.
Summary: Supports innovative research to advance understanding, diagnosis, and therapy development for CDKL5 Deficiency Disorder.
Key Information: By invitation only: requires Letter of Intent and, if invited, a full application.
Description
The CDKL5 Pilot Grant Programme, funded by the Loulou Foundation, aims to accelerate scientific discoveries and therapeutic development for CDKL5 Deficiency Disorder (CDD), a severe neurodevelopmental disease caused by mutations in the CDKL5 gene. The program funds innovative, high-impact research exploring the molecular, cellular, and physiological mechanisms underlying CDD, as well as the development of new disease models, biomarkers, and potential treatment strategies. The initiative fosters global collaboration among leading researchers to translate findings into meaningful progress for individuals affected by CDKL5-related conditions.
